Target & Activity
| Target | Activity | Value |
|---|---|---|
| Topoisomerase II | ||
| Topoisomerase IV |
Fig. 1 · Structure
Documents & Downloads
Moxifloxacin HCl
Cat. No.
A10609
CAS
186826-86-8
Topoisomerase inhibitor
Moxifloxacin is a quinolone/fluoroquinolone antibiotic.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Biological Activity
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 186826-86-8 |
| Applications | Topoisomerase inhibitor |
| Formula | C21H24FN3O4.HCl |
| Molecular Weight | 437.9 |
| Synonyms | Avelox; Avalox; BAY 12-8039 |
| SMILES | COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
| Solvent | Reported Solubility |
|---|---|
| DMSO | 77 mg/mL (175.84 mM) |
| Water | 53 mg/mL (121.03 mM) |
| Ethanol | Insoluble |
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
In Vivo Preparation
- Concentration
- 28 mg/mL
- Vehicle
- 30% PEG400+0.5% Tween80+5% propylene glycol
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.
Publications
3 publications citing this product
-
Qinlong Yu, .et al. , Infect Drug Resist, 2025, Oct 4;18:5239-5247 PMID: 41069760
-
Hiroshi Arakawa, .et al. , Biopharm Drug Dispos, 2016, Jan;37(1):39-45 PMID: 26590007
-
Arisa Higa, .et al. , Fundam. Toxicol. Sci, 2016, 3(2): 47-53